Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001720580-26-000050
Filing Date
2026-08-05
Accepted
2026-08-05 16:21:00
Documents
83
Period of Report
2026-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q acet-20260630.htm   iXBRL 10-Q 2813663
2 EX-10.1 acet-ex10_1.htm EX-10.1 99570
3 EX-31.1 acet-ex31_1.htm EX-31.1 17072
4 EX-31.2 acet-ex31_2.htm EX-31.2 17094
5 EX-32.1 acet-ex32_1.htm EX-32.1 13801
  Complete submission text file 0001720580-26-000050.txt   10920998

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT acet-20260630.xsd EX-101.SCH 1467542
87 EXTRACTED XBRL INSTANCE DOCUMENT acet-20260630_htm.xml XML 1853954
Mailing Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116
Business Address 131 DARTMOUTH STREET 3RD FLOOR BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1226
Type: 10-Q | Act: 34 | File No.: 001-38359 | Film No.: 261243915
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)